No abstract

Hypernatremia in mixed DKA and HHS Choo et al.

We propose a scheme that combines velocity-selective coherent population trapping (CPT) and Raman sideband cooling (RSC) for subrecoil cooling of optically trapped atoms outside the Lamb-Dicke regime. This scheme is based on an inverted Y configuration in an alkali-metal atom. It consists of a Λ formed by two Raman transitions between the ground hyperfine levels and the D transition, allowing RSC along two paths and formation of a CPT dark state. Using statedependent difference in vibration frequency of the atom in a circularly polarized trap, we can tune the Λ to make only the motional ground state a CPT dark state. We call this scheme motionselective coherent population trapping (MSCPT). We write the master equations for RSC and MSCPT and solve them numerically for a 87 Rb atom in a one-dimensional optical lattice when the Lamb-Dicke parameter is 1. Although MSCPT reaches the steady state slowly compared with RSC, the former consistently produces colder atoms than the latter. The numerical results also show that subrecoil cooling by MSCPT outside the Lamb-Dicke regime is possible under a favorable, yet experimentally feasible, condition. We explain this performance quantitatively by calculating the relative darkness of each motional state. Finally, we discuss on application of the MSCPT scheme to an optically trapped diatomic polar molecule whose Stark shift and vibration frequency exhibit large variations depending on the rotational quantum number.

Purpose: The first-line antithyroid drug for children and adolescents with Graves’ disease (GD) is methimazole (MMI). This study evaluated the relationship between the initial MMI dose and the clinical course of GD after treatment.Methods: We studied the efficacy of the initial MMI dose and the relationship between the initial MMI dose and adverse events (AEs). We retrospectively enrolled 22 males and 77 females and divided those subjects into 3 groups according to the initial dose of MMI: <0.4 mg/kg/day (group A; n=32); 0.4–0.7 mg/kg/day (group B; n=39); and >0.7 mg/kg/day (group C; n=28).Results: The mean time to the normalization of free thyroxine (fT4) levels upon initial treatment was 5.64, 8.61, and 7.98 weeks in groups A, B, and C, respectively (P=0.116). The incidence of liver dysfunction, neutropenia, and skin rash was 12.5%, 20.5%, and 42.9% in groups A, B, and C, respectively (P=0.018). Neutropenia, as a severe AE, was absent in group A, but its prevalence was 7.7% in group B and 21.4% in group C (P=0.015). When comparing only groups B and C, the incidences of liver dysfunction and neutropenia were higher in group C (P=0.04 and P=0.021, respectively).Conclusion: The mean time to the normalization of fT4 levels did not differ among the 3 groups, but the incidence of AEs was higher in the groups that received high MMI doses. High doses of MMI (>0.7 mg/kg/day) should be reconsidered as an initial treatment for children and adolescents with GD.